PharmaEssentia and AOP Orphan Receive Positive CHMP Opinion Fo...
WALTHAM, Mass., Dec. 17, 2018 /PRNewswire-AsiaNet/ -- PharmaEssentia, a global biopharmaceutical company focused on developing and commercializing novel treatments for treatment of rare diseases, today announced that the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion...
Read more https://view-release/?pr-id=76800